Dr. Teresa Woodruff, Director of the Oncofertility Consortium and Northwestern’s Women’s Health Research Institute will be featured on Chicago Tonight on WTTW, Channel 11, tonight at 7pm CST. Dr. Woodruff, along with Dr. Melina Kibbe from Northwestern Medicine, were driving forces behind the push for the NIH to require females in all preclinical research studies; from cells to animals. Tune in if you can!
Registration is now open for the 2014 Oncofertility Conference, Bench to Bedside: Oncofertility Advances in Males and Females which takes place September 22-23, 2014 in Chicago, IL.
This year’s conference will attract more than 150 researchers, clinicians, advocates and trainees from around the globe who are dedicated to ensuring reproductive health for cancer survivors whose disease or treatment may impair fertility.
This year, we are excited to expand the number and scope of training courses offered in conjunction with the 2014 Oncofertility Conference, Bench to Bedside: Oncofertility Advances in Males and Females. In addition to our exciting Day 1 agenda full of presentations and case studies by Oncofertility leaders, we have elected to have 2 clinical-based training courses and 2 lab-based training courses on Day 2 with a shared luncheon to allow for additional networking and communication between researchers and clinicians.
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University is proud to host a Cancer Survivors’ Celebration Walk & 5K on Sunday, June 1st in Chicago’s Grant Park. No pledges are required to participate and registration is open until May 30th.
This wonderful event includes a non-competitive walk along the lakefront or a chip-timed 5K race, picnic, family entertainment, Dedication wall, and more. Join survivors, families, friends, physicians, scientists, and health professionals to celebrate our survivors! The celebration begins at 7:30am and we hope to see you there.
The Korean Society for Fertility Preservation
The Oncofertility Consortium is pleased to announce another Global Partner in Korea: The Korean Society for Fertility Preservation (KSFP). Please see below information provided by KSFP in both English and Korean and review the Oncofertility Global Partners webpage to learn more.
The Korean Society for Fertility Preservation (KSFP) was created in 2013 to help collaboration between the medical doctors and researchers who specialize in reproductive medicine and oncology. The ultimate purpose of this society is to help patients undergoing treatments affecting their fertilityand reproductive function. The goals of KSFP are academic education, networking, advertisement, discussion and development of standard protocol forfertility preservation.
KSFP holds an annual conference and lecture. Furthermore, the society has established a national fertility preservation network with a regional center hospital in each state to implement the use of fertility preservation. This network hopes to improve the quality of treatment and to achieve the same level of productivity in each state. KSFP is pursuing a clinical guideline for fertility preservation in the future. The president is Prof. Seok Hyun Kim in Seoul National University College of Medicine.
대한가임력보존학회 (The Korean Society for Fertility Preservation) 은 가임력보존 치료에 대한 의료인 및 연구자들간의 학술적인 교류 및 교육, 가임력보존에 대한 홍보 강화, 가임력보존의 표준 치료방침 논의 및 개발 등의 목적을 위해 보다 많은 관련 분야의 의료인과 연구자들의 협력을 위해 2013년 창립되었습니다.
주된 활동은 각각 연 1회의 연수강좌와 학술대회의 개최 외에도, 전국적인 가임력보존 치료의 활성화와 전국 동일 수준의 가임력보존 치료의 달성을 위해 전국 가임력보존 네트워크 (National Fertility Preservation Network)를 확립하여 각 지역의 거점병원을 선정하고, 거점병원에 대한 기술이전을 통해 각 지역에서의 가임력보존 치료의 수준을 향상시키고, 나아가 지역거점병원을 중심으로 지역내의 가임력보존 치료의 활성화와 치료수준의 향상을 도모하고자 노력하고 있습니다. 또한 가임력보존 치료의 표준 치료지침 (Clinical Guideline)의 작성을 추진과제로 하고 있습니다. 회장님은 서울의대 산부인과학 교실 김 석현 교수님이십니다.
UPDATE: NEW VENUE INFORMATION BELOW!
Wednesday June 25th @7:00pm
Rockit Bar & Grill
22 W Hubbard St
Chicago, Illinois 60654
Got cancer? Under 40? Sucks, huh? Well, its time to get busy living with an official Stupid Cancer Meetup, made possible by your friends over at Stupid Cancer, a non-profit organization that empowers young adults affected by cancer through innovative and award-winning programs and services.
Come out for a very special meetup with Stupid Cancer founder and CEO, Matthew Zachary. Learn about his experiences as a young adult survivor and how it drove him to create the most prominent nonprofit focusing on young adults affected by cancer. Additionally, learn about Stupid Cancer’s programs and initiatives, including the OMG! Cancer Summits, Cancer Con, Instapeer, boot camps, town halls, and more. Hear from past attendees and ask all your burning questions.
It’s time to get busy living – and we’ll see you there! To learn more about Stupid Cancer, visit stupidcancer.org.
The National Institutes of Health (NIH) is hosting a contest for songs and videos demonstrating the cutting edge science funded by the office of the director. The Oncofertility Consortium has two videos in the running and we’d love your support!
To vote for our videos, follow the links below and cast your vote by clicking the ‘like‘ button.
The Oncofertility Saturday Academy
Thanks for helping us spread the word about the exciting research being done through the Oncofertility Consortium!
The Global Partner: The Cheil General Hospital (CGH) & Women’s Healthcare Center in Seoul, Korea! We had the pleasure of hosting Dr. Chanwoo Park last week at the offices here in Chicago, IL to discuss Global Partnership and introduce him to Oncofertility Consortium members. We asked him to write a brief blog about his institution which we’ve shared below in both English and Korean. Please join us in welcoming The Cheil General Hospital and Women’s Healthcare Center as another Oncofertility Global Partner!is excited to announce another
The Cheil General Hospital (CGH) & Women’s Healthcare Center was founded in 1963 and became the first medical institution in Korea dedicated specifically to women. For the past 50 years, CGH has been a pioneer in the advancement of women’s medicine and has upheld the “patient first” philosophy by providing medical services of the highest quality. CGH currently operates 16 departments and 32 specialized clinics. CGH has established Korea’s infertility treatment. In fact, CGH features one of the highest success rates in in vitro fertilization (IVF) and embryo, oocyte freezing. CGH was the first private hospital to successfully use IVF with frozen embryos in Asia. Currently, 4,500 eggs and embryos are frozen each year at CGH. Further, the relative success rate of IVF with previously frozen embryos is much higher at CGH than at the Society for Assisted Reproductive Technology (SART). In addition to treating cancer, the Women Cancer Center of CGH extends fertility preservation resources to all their patients.
제일병원 미래맘 가임보존센터는 가임보존을 위한 체계적인 의료를 제공합니다.
아시아 최초 동결배아이식 성공이라는 역사를 바탕으로 꾸준히 연구한 결과 동결란 분야에서 세계적인 성공률을 얻고있습니다. 난자와 배아의 발달에 따른 최적의 동결보존 방법을 사용하고 있으며 융해시 90% 이상의 생존율을 나타내고 있습니다. 현재 매년 4500여 개의 난자와 배아를 동결하고 있으며, 동결란 이식주기 성공율은 SART에서 보고하고 있는 자료보다 높은 결과를 보여주고 있습니다. 다양한 동결기기와 최고의 의료진과 연구진의 지속적인 노력과 연구를 통하여 성공적인 임신에 최선을 다하고 있습니다.
We thank Dr. Park for his visit and welcome him and The Cheil General Hospital & Women’s Healthcare Center to the Oncofertility Consortium. Special thanks goes to Woodruff Lab member, So-Youn Kim, PhD, for facilitating his visit. Review our Oncofertility Consortium Global Partner webpages and learn more about our wide-reaching collaborators.
SHARE Cancer Support is hosting an educational event, Having Children After Cancer, on Wednesday, May 14th from 6:00-7:30pm EST. Dr. Diana Chavkin, Reproductive Endocrinology and Infertility (REI) specialist at Genesis Fertility and Reproductive Medicine, will discuss fertility preservation options before and after cancer treatment with a Q&A session to follow. This event is available both in-person and via Webinar and is open to the public. Register online or email email@example.com and indicate whether you will attend in person or online. Don’t miss this exciting event!
Date: Wednesday, May 14, 2014
Time: 6:00-7:30pm (Eastern Time)
Location: Online or in-person
SHARE Main Office
1501 Broadway, Suite 704A
The Repropedia is a reproductive dictionary created by an international team of scientists and clinicians led by investigators at . This site provides information on common reproductive science terms that can be very useful to patients and providers.is happy to announce the translation of Repropedia into Portuguese.
Dr. Teresa Almeida Santos of the Portuguese Oncofertility Society translated Repropedia into Portuguese and it was recently posted to the website for easy access. The newest translation can be found here: http://oncofertility.northwestern.edu/portuguese-repropedia-vers%C3%A3o-portuguesa-de-portugal.
The Oncofertility Consortium is pleased to welcome Dr. Jennifer Hirshfeld-Cytron as a guest blogger today.
This is a blog post based on the article, Toward theoretical understanding of the fertility preservation decision-making process: examining information processing among young women with cancer by authors P.E. Hershberger, L. Finnegan, S. Altfeld, S. Lake, and J. Hirshfeld-Cytron, in Research and Theory for Nursing Practice.
By: Jennifer Hirshfeld-Cytron, MD/MSCI
Despite a clear desire among cancer patients to receive oncofertility counseling, studies have shown about a third of patients do not follow up with care following the consultation. Increased attention is being drawn to the process of decision making and the best ways to deliver information. In addition, what is the process of which information can be successfully processed and a decision made during such a stressful time?
As health care providers, we constantly strive to make sure we are accurately discussing medical data with our patients. Furthermore, our goal is to help patients come to a decision that they are comfortable with based on sound scientific evidence and their unique perspectives. This process is even more important when approaching a subject such as oncofertility which is elective and involves planning for the cancer remission phase, newly after an initial cancer diagnosis is made.
Using a qualitative approach and decision theory we conducted in depth interviews of 27 women with a recent cancer diagnosis that were eligible for fertility preservation. We discovered that 85% reported receiving counseling, but a majority reported that they felt it was inadequate. Woman often go to the internet for supplemental material; in particular they are interested in learning other woman’s experiences. Health care providers could provide accurate websites such as myoncofertility.org to assure patients are receiving medically sound information. This site also provides patient’s stories. Our analysis further suggests using broad probing questions during the consultation should be used judiciously as women are often unsure of what questions to ask clinicians regarding how their particular needs impact their fertility preservation options. Having an organized informational approach and a collaborative and cohesive medical team were all essential strategies that can facilitate decision making. In particular, navigating the medical system can be overwhelming and informing patients about how to navigate the system and using patient navigators can enhance the patient experience.
A true collaborative team across specialties and between MDs, nurses, social workers, and other clinicians such as patient navigators is also essential; particularly as members of the support team engage in what are research identified as “decisional debriefing sessions.” These debriefing sessions are focused aspects of counseling sessions where active information processing takes place. Assuring that women receive an oncofertility consultation is only the beginning, in this next phase of fertility preservation we need to assure patients are undergoing productive consultations in the context of a larger collaborative medical team.